Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03619044
Brief Title: The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (REVER)

First Submitted : August 1, 2018
First Submitted that Met QC Criteria : August 1, 2018
First Posted : August 7, 2018

Last Update Submitted that Met QC Criteria : December 2, 2019
Last Update Posted : December 4, 2019